Hydrogenology
Hydrogenology editorial study record

Evaluation of the effect of enriched hydrogen saline solution on distant organ (lung) damage in skeletal muscle ischemia reperfusion in rats

Özer A, Erel S, Küçük A, Demirtaş H, Sezen ŞC, Boyunağa H, Oktar GL, Arslan M. · 2024.

PreclinicalOther formsPublished 2024
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Preclinical

Reported design

Controlled rat ischemia-reperfusion study

Research topic

Critical care and ischemia-reperfusion

Administration classification

Other forms

Study result signal

Positive preclinical signal.

Outcome type

Remote-organ tissue and biomarker outcomes in rats.

Reported in the source

Methods at a glance

Population or model

Rats with lower-limb ischemia-reperfusion and subsequent lung assessment.

Sample

Study groups and assay counts were checked in the full article.

Duration

30 minutes pretreatment, 120 minutes ischemia and 120 minutes reperfusion.

Intervention

Hydrogen-enriched saline around the ischemia-reperfusion procedure.

Hydrogen form

H₂ dissolved in saline.

H₂ specification

0.6 mmol/L; 10 mL administered under the article protocol.

H₂ flow

Not applicable.

O₂ delivered with H₂

No oxygen was co-delivered.

Comparator

Sham and untreated ischemia-reperfusion groups.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Lung histology, oxidative-stress markers and inflammatory measures.

Reported result

Several lung-injury, oxidative and inflammatory measures favored hydrogen-enriched saline over untreated ischemia-reperfusion.

Results-extraction completeness

The full article was checked for methods, intervention details, outcomes, positive and null findings, funding and conflicts. This record does not imply medical efficacy.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

Animal evidence only; short experimental follow-up and several biochemical endpoints.

Applies directly to

The reported rat limb-ischemia model only.

Preliminary appraisal framework

SYRCLE animal-study tool — preliminary

Preliminary risk-of-bias status

Some concerns

Appraisal rationale

Comparator groups were reported, but concealment and blinded histological assessment were not established.

Appraisal domains

Sequence generation checked where reported · Allocation concealment generally unclear · Personnel blinding generally unclear · Outcome-assessor blinding generally unclear · No prospectively registered analysis plan identified

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 38807538 · DOI: 10.1177/00368504241257060

Publisher access

A free full article is available through PubMed Central.

Extraction basis

Official PubMed Central full article and PubMed bibliographic record; source identity, methods, intervention, results, funding and conflicts checked 10 August 2026.

Record revision

2026-08-10